Anzeige
Erschienen in:
01.06.2015
CME instructions: Clinical topic: Nuclear imaging in hypertrophic cardiomyopathy
Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2015
Einloggen, um Zugang zu erhaltenExcerpt
The following gaps in knowledge have been identified in clinical practice demonstrating the learner’s need to acquire the skills and strategies presented in this CME activity.
1.
Hypertrophic cardiomyopathy, defined by the presence of abnormally increased left ventricular wall thickness (≥15 mm), is characterized by myocyte disarray, interstitial and replacement fibrosis, abnormal mitral valve anatomy, and coronary microvascular dysfunction.
2.
These structural and functional abnormalities cause left ventricular systolic and diastolic dysfunctions, left ventricular outflow tract obstruction, chest pain, cardiac arrhythmias, and sudden cardiac death.
3.
While transthoracic echocardiography and cardiac magnetic resonance are the most frequently used imaging techniques to evaluate patients with hypertrophic cardiomyopathy, nuclear imaging techniques are valuable tools to refine the phenotyping and risk stratification processes of these patients.